Patents : |  |
| US Patent No. | Title |
| 7416726 | Enhancement of antibody-mediated immune responses
|
| 7425651 | Jasmonate derivative compounds, pharmaceuticals compounds and methods of use thereof
|
| 7427400 | Methods of cancer diagnosis and therapy targeted against a cancer stem line
|
| 7427605 | Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
|
| 7427638 | (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminois- oindoline-1,3-dione:, and methods of synthesis and compositions thereof
|
| 7429382 | Antibodies that bind cell-associated CA 125/O772P and methods of use thereof
|
| 7429481 | Targeting viruses using a modified sindbis glycoprotein
|
| 7429571 | Therapeutic furopyrimidines and thienopyrimidines
|
| 7429639 | SSX-2 peptides presented by HLA class II molecules
|
| 7432236 | Vasostatin as marrow protectant
|
| 7432300 | Gossypol co-crystals and the use thereof
|
| 7425620 | Fc.gamma.RIIB-specific antibodies and methods of use thereof
|
| 7425619 | Fc.gamma.RIIB specific antibodies and methods of use thereof
|
| 7425553 | Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
|
| 7419991 | 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereof
|
| 7420000 | Amino phosphonate and amino bis-phosphonate derivatives
|
| 7420034 | HLA-A24-restricted cancer antigen peptides
|
| 7420044 | Nucleic acid and protein homologs and uses thereof
|
| 7422738 | Combined cancer treatment methods using antibodies to aminophospholipids
|
| 7422741 | VEGFR-3 fusion proteins
|
| 7422899 | Antibodies to the human prolactin receptor
|
| 7423116 | Pentapeptide compounds and uses related thereto
|
| 7425325 | Cytokine zcytor17 ligand polypeptides
|
| 7425548 | Materials and methods for immune system stimulation
|
| 7432303 | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
|
| 7432304 | Small molecule antagonists of Bcl-2 family proteins
|
| 7442381 | Alphavirus replicons and helper constructs
|
| 7442778 | Modified Fc molecules
|
| 7442784 | Ligand activated transcriptional regulator proteins
|
| 7445794 | Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors
|
| 7446171 | SIGIRR DNA and polypeptides
|
| 7449555 | Antibodies of angiogenesis inhibiting domains CD148
|
| 7449557 | Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
| 7449570 | Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
|
| 7452866 | Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1
|
| 7455833 | Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
|
| 7439346 | Nucleic acids arrays and methods of use therefor
|
| 7439051 | Process for utilizing epitopes recognized by natural antibodies
|
| 7439032 | Methods to identify compounds useful for tumor sensitization to DNA damage
|
| 7432369 | Pyridyl-substituted porphyrin compounds and methods of use thereof
|
| 7435550 | Methods of using cytokine receptor zalpha11 to detect its ligands
|
| 7435589 | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
| 7435596 | Modified cell line and method for expansion of NK cell
|
| 7435719 | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
|
| 7435750 | Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
| 7435755 | CDDO-compounds and combination therapies thereof
|
| 7438854 | Biomolecule substrate, and test and diagnosis methods and apparatuses using the same
|
| 7438911 | Antibody against human insulin-like growth factor
|
| 7438931 | Methods and compositions for the treatment of angiogenic diseases
|
| 7456256 | BGS 4
|
